These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34806372)

  • 21. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
    Dalela M; Shrivastav TG; Kharbanda S; Singh H
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
    Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
    Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
    Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
    Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance.
    Su Y; Hu J; Huang Z; Huang Y; Peng B; Xie N; Liu H
    Drug Des Devel Ther; 2017; 11():659-668. PubMed ID: 28293102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A computer-aided, heterodimer-based "triadic" carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency.
    Yang L; Zhang Y; Lai Y; Xu W; Lei S; Chen G; Wang Z
    J Colloid Interface Sci; 2025 Jan; 677(Pt B):523-540. PubMed ID: 39154445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.
    Chowdhury P; Nagesh PKB; Hatami E; Wagh S; Dan N; Tripathi MK; Khan S; Hafeez BB; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
    J Colloid Interface Sci; 2019 Feb; 535():133-148. PubMed ID: 30292104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN
    Liang YX; Sun XY; Xu DZ; Gao YN; Tang Q; Lu ZL; Liu Y
    ACS Appl Bio Mater; 2024 May; 7(5):3202-3214. PubMed ID: 38651918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
    Chen S; Zhang Z; Zhang J
    Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
    [No Abstract]   [Full Text] [Related]  

  • 30. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
    Diab T; Alkafaas SS; Shalaby TI; Hessien M
    Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance.
    Liping Y; Jian H; Zhenchao T; Yan Z; Jing Y; Yangyang Z; Jing G; Liting Q
    Drug Deliv; 2022 Dec; 29(1):229-237. PubMed ID: 35001781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release.
    Yuan L; Chen W; Hu J; Zhang JZ; Yang D
    Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionalization of Silver Nanoparticles Loaded with Paclitaxel-induced A549 Cells Apoptosis Through ROS-Mediated Signaling Pathways.
    Zou J; Zhu B; Li Y
    Curr Top Med Chem; 2020; 20(2):89-98. PubMed ID: 31648639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
    Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
    Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
    Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
    Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redox-responsive paclitaxel-pentadecanoic acid conjugate encapsulated human serum albumin nanoparticles for cancer therapy.
    Zhang Y; Wang J; Xing H; Liu C; Li X
    Int J Pharm; 2023 Mar; 635():122761. PubMed ID: 36822341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy.
    Jiang B; Hao D; Li C; Lu S; Pei Q; Xie Z
    J Mater Chem B; 2021 Dec; 9(48):9971-9979. PubMed ID: 34871339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.